| 0.004 |
squamous cell carcinoma |
NA |
BeFree,LHGDN |
|
Detail |
| 0.002 |
chorioamnionitis |
NA |
GAD |
|
Detail |
| <0.001 |
colorectal carcinoma |
NA |
BeFree |
|
Detail |
| <0.001 |
Diabetes Mellitus, Insulin-Dependent |
NA |
BeFree |
|
Detail |
| 0.003 |
Diabetes Mellitus, Non-Insulin-Dependent |
The association of soluble IGF2R and IGF2R gene polymorphism with type 2 diabete... |
BeFree,GAD |
25922844 |
Detail |
| 0.002 |
Esophageal Neoplasms |
NA |
GAD |
|
Detail |
| 0.003 |
Fanconi syndrome |
NA |
LHGDN |
|
Detail |
| 0.002 |
Fetal Membranes, Premature Rupture |
NA |
GAD |
|
Detail |
| <0.001 |
Glycogen Storage Disease Type I |
NA |
BeFree |
|
Detail |
| <0.001 |
Glycogen storage disease type II |
NA |
BeFree |
|
Detail |
| <0.001 |
hemangioma |
NA |
BeFree |
|
Detail |
| <0.001 |
hepatitis |
NA |
BeFree |
|
Detail |
| <0.001 |
hepatitis A |
NA |
BeFree |
|
Detail |
| <0.001 |
HIV Infections |
NA |
BeFree |
|
Detail |
| 0.002 |
Kidney Failure, Chronic |
NA |
GAD |
|
Detail |
| 0.002 |
Premature Obstetric Labor |
NA |
GAD |
|
Detail |
| 0.002 |
chronic lymphocytic leukemia |
NA |
GAD |
|
Detail |
| <0.001 |
Leukemia, Lymphocytic, Acute, L1 |
NA |
BeFree |
|
Detail |
| <0.001 |
liver cirrhosis |
NA |
BeFree |
|
Detail |
| 0.003 |
Liver neoplasms |
NA |
BeFree,GAD |
|
Detail |
| 0.080 |
Liver Neoplasms, Experimental |
NA |
RGD |
|
Detail |
| 0.120 |
Lung diseases |
NA |
CTD_human |
|
Detail |
| 0.002 |
Chronic Obstructive Airway Disease |
NA |
GAD |
|
Detail |
| 0.083 |
Lung Neoplasms |
NA |
BeFree,LHGDN,RGD |
|
Detail |
| 0.002 |
Lymphoma, Non-Hodgkin |
NA |
GAD |
|
Detail |
| <0.001 |
Malignant neoplasm of stomach |
Increased expression of ATG-5 and MPR-1 was significantly correlated with poor o... |
BeFree |
25329677 |
Detail |
| <0.001 |
Metabolic syndrome X |
For the SNP genotypes of rs362551 (SNAP25), rs3818569 (RXRG), rs1479355, rs15700... |
BeFree |
25867398 |
Detail |
| 0.002 |
Animal Mammary Neoplasms |
NA |
GAD |
|
Detail |
| <0.001 |
melanoma |
NA |
BeFree |
|
Detail |
| <0.001 |
premature menopause |
NA |
BeFree |
|
Detail |
| 0.002 |
multiple sclerosis |
NA |
GAD |
|
Detail |
| <0.001 |
myocardial infarction |
NA |
BeFree |
|
Detail |
| <0.001 |
Neoplasm Metastasis |
NA |
BeFree |
|
Detail |
| <0.001 |
nephroblastoma |
NA |
BeFree |
|
Detail |
| 0.005 |
obesity |
NA |
GAD |
|
Detail |
| 0.005 |
osteosarcoma |
NA |
BeFree,GAD,LHGDN |
|
Detail |
| <0.001 |
ovarian carcinoma |
NA |
BeFree |
|
Detail |
| 0.002 |
Pancreatic Neoplasm |
NA |
GAD |
|
Detail |
| 0.120 |
Parkinson disease |
NA |
CTD_human |
|
Detail |
| <0.001 |
pneumonia |
NA |
BeFree |
|
Detail |
| 0.002 |
polycystic ovary syndrome |
NA |
GAD |
|
Detail |
| 0.002 |
pre-eclampsia |
NA |
GAD |
|
Detail |
| <0.001 |
Precancerous Conditions |
NA |
BeFree |
|
Detail |
| 0.005 |
Prostatic Neoplasms |
NA |
LHGDN |
|
Detail |
| 0.002 |
Delayed puberty |
NA |
GAD |
|
Detail |
| 0.002 |
Precocious Puberty |
NA |
GAD |
|
Detail |
| <0.001 |
retinoblastoma |
NA |
BeFree |
|
Detail |
| 0.002 |
Stomach Neoplasms |
NA |
GAD |
|
Detail |
| <0.001 |
Thyroid Neoplasm |
NA |
BeFree |
|
Detail |
| 0.002 |
Tobacco use disorder |
NA |
GAD |
|
Detail |
| <0.001 |
Virus Diseases |
NA |
BeFree |
|
Detail |
| 0.003 |
Ovarian Failure, Premature |
NA |
BeFree,GAD |
|
Detail |
| <0.001 |
Squamous cell carcinoma of lung |
NA |
BeFree |
|
Detail |
| 0.002 |
Premature Birth |
NA |
GAD |
|
Detail |
| <0.001 |
renal fibrosis |
NA |
BeFree |
|
Detail |
| 0.003 |
Malignant neoplasm of mouth |
NA |
BeFree,GAD |
|
Detail |
| <0.001 |
HIV Encephalopathy |
NA |
BeFree |
|
Detail |
| <0.001 |
hepatocellular adenoma |
NA |
BeFree |
|
Detail |
| 0.003 |
adrenocortical carcinoma |
NA |
LHGDN |
|
Detail |
| <0.001 |
cholangiocarcinoma |
NA |
BeFree |
|
Detail |
| <0.001 |
Lip and oral cavity carcinoma |
NA |
BeFree |
|
Detail |
| 0.120 |
congenital diaphragmatic hernia |
NA |
CTD_human |
|
Detail |
| <0.001 |
pancreatic carcinoma |
NA |
BeFree |
|
Detail |
| 0.005 |
Malignant neoplasm of lung |
NA |
BeFree,GAD |
|
Detail |
| <0.001 |
Turcot syndrome (disorder) |
NA |
BeFree |
|
Detail |
| <0.001 |
HIV encephalitis |
NA |
BeFree |
|
Detail |
| <0.001 |
Malignant Childhood Neoplasm |
NA |
BeFree |
|
Detail |
| <0.001 |
Cancer of Head and Neck |
NA |
BeFree |
|
Detail |
| <0.001 |
Liver and Intrahepatic Biliary Tract Carcinoma |
NA |
BeFree |
|
Detail |
| <0.001 |
laryngeal squamous cell carcinoma |
NA |
BeFree |
|
Detail |
| <0.001 |
Microglial nodules |
NA |
BeFree |
|
Detail |
| <0.001 |
Adult Fanconi syndrome |
NA |
BeFree |
|
Detail |
| <0.001 |
Generalized glycogen storage disease of infants |
NA |
BeFree |
|
Detail |
| <0.001 |
Malignant neoplasm of liver |
NA |
BeFree |
|
Detail |
| <0.001 |
Malignant neoplasm of pancreas |
NA |
BeFree |
|
Detail |
| <0.001 |
Helicobacter pylori (H. pylori) infection in conditions classified elsewhere and of unspecified site |
NA |
BeFree |
|
Detail |
| 0.003 |
Malignant neoplasm of prostate |
The results demonstrated the efficiency of M6PR targeting for prostate cancer th... |
BeFree,GAD |
25802144 |
Detail |
| 0.002 |
thrombophilia |
NA |
GAD |
|
Detail |
| <0.001 |
endometrial carcinoma |
NA |
BeFree |
|
Detail |
| <0.001 |
Osteosarcoma of bone |
NA |
BeFree |
|
Detail |
| 0.002 |
Carcinogenesis |
NA |
BeFree |
|
Detail |
| 0.001 |
prostate carcinoma |
The results demonstrated the efficiency of M6PR targeting for prostate cancer th... |
BeFree |
25802144 |
Detail |
| 0.002 |
Epithelial ovarian cancer |
NA |
GAD |
|
Detail |
| 0.003 |
breast carcinoma |
NA |
BeFree |
|
Detail |
| <0.001 |
Carcinoma of lung |
NA |
BeFree |
|
Detail |
| <0.001 |
Malignant neoplasm of gastrointestinal tract |
NA |
BeFree |
|
Detail |
| <0.001 |
stomach carcinoma |
Increased expression of ATG-5 and MPR-1 was significantly correlated with poor o... |
BeFree |
25329677 |
Detail |
| <0.001 |
Dissecting aneurysm of the thoracic aorta |
NA |
BeFree |
|
Detail |
| 0.120 |
Lewy Body Disease |
NA |
CTD_human |
|
Detail |
| <0.001 |
Helicobacter pylori infection |
NA |
BeFree |
|
Detail |
| <0.001 |
Invasive breast carcinoma |
NA |
BeFree |
|
Detail |
| <0.001 |
ovarian neoplasm |
NA |
BeFree |
|
Detail |
| <0.001 |
Malignant neoplasm of ovary |
NA |
BeFree |
|
Detail |
| <0.001 |
Squamous cell carcinoma of the head and neck |
NA |
BeFree |
|
Detail |
| <0.001 |
sarcoma |
NA |
BeFree |
|
Detail |
| 0.006 |
Mammary Neoplasms |
NA |
BeFree,GAD,LHGDN |
|
Detail |
| 0.002 |
Hepatocarcinogenesis |
NA |
BeFree |
|
Detail |
| <0.001 |
colorectal cancer |
NA |
BeFree |
|
Detail |
| <0.001 |
DIABETES MELLITUS, INSULIN-DEPENDENT, 8 |
NA |
BeFree |
|
Detail |
| 0.002 |
Infection of amniotic sac and membranes, unspecified, unspecified trimester, not applicable or unspecified |
NA |
GAD |
|
Detail |
| 0.003 |
Infection |
NA |
LHGDN |
|
Detail |
| <0.001 |
Pneumonitis |
NA |
BeFree |
|
Detail |
| 0.005 |
adenocarcinoma |
NA |
BeFree,GAD |
|
Detail |
| 0.003 |
adenoma |
NA |
BeFree,LHGDN |
|
Detail |
| 0.125 |
Alzheimer's disease |
Together, these results highlight the potential contribution of IGF-II receptor ... |
BeFree,CTD_human,GAD,LHGDN |
25939386 |
Detail |
| 0.080 |
amyotrophic lateral sclerosis |
NA |
RGD |
|
Detail |
| <0.001 |
Arterial Occlusive Diseases |
NA |
BeFree |
|
Detail |
| <0.001 |
Beckwith-Wiedemann syndrome |
NA |
BeFree |
|
Detail |
| 0.002 |
Malignant neoplasm of urinary bladder |
NA |
GAD |
|
Detail |
| 0.002 |
Bone neoplasms |
NA |
GAD |
|
Detail |
| 0.003 |
Brain Neoplasms |
NA |
BeFree,GAD |
|
Detail |
| 0.008 |
Malignant neoplasm of breast |
NA |
BeFree,GAD |
|
Detail |
| <0.001 |
Non-small cell lung carcinoma |
IGF2R expression is associated with the chemotherapy response and prognosis of p... |
BeFree |
25402559 |
Detail |
